Merck & Co., Inc.·4

May 1, 5:45 PM ET

Guindo Chirfi 4

4 · Merck & Co., Inc. · Filed May 1, 2025

Insider Transaction Report

Form 4
Period: 2025-04-29
Guindo Chirfi
Chief Marketing Officer
Transactions
  • Award

    Restricted Stock Unit

    2025-04-29+5,9025,902 total
    From: 2026-04-29Exp: 2028-04-29Common Stock (5,902 underlying)
  • Award

    Stock Option (Right to Buy)

    2025-04-29+26,86726,867 total
    Exercise: $84.71From: 2026-04-29Exp: 2035-04-28Common Stock (26,867 underlying)
Holdings
  • Common Stock

    69,826.125
  • Common Stock-401(k) Plan

    (indirect: By 401(k))
    55.416
Footnotes (5)
  • [F1]Holdings include shares acquired in dividend reinvestment transactions.
  • [F2]Includes shares acquired and dividends earned through April 7, 2025 in the Merck U.S. Savings Plan, a 401(k) plan.
  • [F3]Each restricted stock unit represents a contingent right to receive one share of Merck & Co., Inc. common stock.
  • [F4]These restricted stock units vest and are distributed as shares of Merck & Co., Inc. common stock in three equal installments on 4/29/2026, 4/29/2027 and 4/29/2028.
  • [F5]The option vests and becomes exercisable in three equal installments on 4/29/2026, 4/29/2027 and 4/29/2028.

Documents

1 file
  • 4
    form4.xmlPrimary

    PRIMARY DOCUMENT